Dissection of cell context-dependent interactions between HBx and p53 family members in regulation of apoptosis: A role for HBV-induced HCC

Cell Cycle

Volumn 10, Issue 20, 2011, Pages 3554-3565

  Knoll, Susanne ^a   Fürst, Katharina ^a   Thomas, Saijo ^a   Baselga, Sergio Villanueva ^a   Stoll, Anja ^a   Schaefer, Stephan ^a   Pützer, Brigitte M ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Apoptosis; Hepatitis B virus X protein; Hepatocellular carcinoma; P53; P73

Indexed keywords

ATM PROTEIN; HEPATITIS B VIRUS X PROTEIN; PROTEIN KINASE C INHIBITOR; PROTEIN P53; PROTEIN P73;

APOPTOSIS; ARTICLE; CELL DEATH; CELL INTERACTION; CELL SURVIVAL; CONTROLLED STUDY; CYTOPLASM; DISSECTION; FIBROBLAST; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR CELL LINE;

HEPATITIS B VIRUS;

EID: 80055101360     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.20.17856     Document Type: Article

References (71)

1. Chan HL, Sung JJ. Hepatocellular carcinoma and hepatitis B virus. Semin Liver Dis 2006; 26:153-61; PMID:16673293; DOI:10.1055/s-2006-939753.
2. Cougot D, Neuveut C, Buendia MA. HBV induced carcinogenesis. J Clin Virol 2005; 34:75-8; PMID:16461228; DOI:10.1016/S1386-6532(05)80014-9.
3. Kremsdorf D, Soussan P, Paterlini-Brechot P, Brechot C. Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis. Oncogene 2006; 25:3823-33; PMID:16799624; DOI:10.1038/sj.onc. 1209559.
4. Sun W, Zhong F, Zhi L, Zhou G, He F. Systematicomics analysis of HBV-associated liver diseases. Cancer Lett 2009; 286:89-95; PMID:19144459; DOI:10.1016/j.canlet.2008.12.002.
5. Nguyen DH, Ludgate L, Hu J. Hepatitis B viruscell interactions and pathogenesis. J Cell Physiol 2008; 216:289-94; PMID:18302164; DOI:10.1002/jcp.21416.
6. Fung J, Lai CL, Yuen MF. Hepatitis B and C virus-related carcinogenesis. Clin Microbiol Infect 2009; 15:964-70; PMID:19874379; DOI:10.1111/j.1469-0691. 2009.03035.x.
7. Chirillo P, Pagano S, Natoli G, Puri PL, Burgio VL, Balsano C, et al. The hepatitis B virus X gene induces p53-mediated programmed cell death. Proc Natl Acad Sci USA 1997; 94:8162-7; PMID:9223332; DOI:10.1073/pnas.94.15.8162.
8. Su F, Schneider RJ. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc Natl Acad Sci USA 1997; 94:8744-9; PMID:9238048; DOI:10.1073/pnas.94.16.8744.
9. Terradillos O, Pollicino T, Lecoeur H, Tripodi M, Gougeon ML, Tiollais P, et al. p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene 1998; 17:2115-23; PMID:9798683; DOI:10.1038/sj.onc.1202432.
10. Diao J, Khine AA, Sarangi F, Hsu E, Iorio C, Tibbles LA, et al. X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with upregulation of the SAPK/JNK pathway. J Biol Chem 2001; 276:8328-40; PMID:11099494; DOI:10.1074/jbc.M006026200.
11. Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Sturzbecher HW, et al. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res 1995; 55:6012-6; PMID:8521383.
12. Seifer M, Hohne M, Schaefer S, Gerlich WH. In vitro tumorigenicity of hepatitis B virus DNA and HBx protein. J Hepatol 1991; 13:61-5; PMID:1822516; DOI:10.1016/0168-8278(91)90026-8.
13. Oguey D, Dumenco LL, Pierce RH, Fausto N. Analysis of the tumorigenicity of the X gene of hepatitis B virus in a nontransformed hepatocyte cell line and the effects of cotransfection with a murine p53 mutant equivalent to human codon 249. Hepatology 1996; 24:1024-33; PMID:8903370; DOI:10.1002/hep.510240508.
14. Schaefer S, Seifer M, Grimmsmann T, Fink L, Wenderhold S, Hohne MW, et al. Properties of tumour suppressor p53 in murine hepatocyte lines transformed by hepatitis B virus X protein. J Gen Virol 1998; 79:767-77; PMID:9568972.
15. Tarn C, Bilodeau ML, Hullinger RL, Andrisani OM. Differential immediate early gene expression in conditional hepatitis B virus pX-transforming versus nontransforming hepatocyte cell lines. J Biol Chem 1999; 274:2327-36; PMID:9890999; DOI:10.1074/jbc.274.4.2327.
16. Shirakata Y, Kawada M, Fujiki Y, Sano H, Oda M, Yaginuma K, et al. The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Jpn J Cancer Res 1989; 80:617-21; PMID:2507484.
17. Höhne M, Schaefer S, Seifer M, Feitelson MA, Paul D, Gerlich WH. Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO J 1990; 9:1137-45; PMID:2323335.
18. Gottlob K, Fulco M, Levrero M, Graessmann A. The hepatitis B virus HBx protein inhibits caspase 3 activity. J Biol Chem 1998; 273:33347-53; PMID:9837909; DOI:10.1074/jbc.273.50.33347.
19. Bréchot C, Gozuacik D, Murakami Y, Paterlini- Brechot P. Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Semin Cancer Biol 2000; 10:211-31; PMID:10936070; DOI:10.1006/scbi.2000.0321.
20. Block TM, Mehta AS, Fimmel CJ, Jordan R. Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003; 22:5093-107; PMID:12910247; DOI:10.1038/sj.onc.1206557.
21. Kanzler S, Galle PR. Apoptosis and the liver. Semin Cancer Biol 2000; 10:173-84; PMID:10936067; DOI:10.1006/scbi.2000.0318.
22. Rich T, Allen RL, Wyllie AH. Defying death after DNA damage. Nature 2000; 407:777-83; PMID:11048728; DOI:10.1038/35037717.
23. Elmore LW, Hancock AR, Chang SF, Wang XW, Chang S, Callahan CP, et al. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc Natl Acad Sci USA 1997; 94:14707-12; PMID:9405677; DOI:10.1073/pnas.94.26.14707.
24. Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR, Harris CC. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity and association with transcription factor ERCC3. Proc Natl Acad Sci USA 1994; 91:2230-4; PMID:8134379; DOI:10.1073/pnas.91.6.2230.
25. Cheng AS, Yu J, Lai PB, Chan HL, Sung JJ. COX-2 mediates hepatitis B virus X protein abrogation of p53- induced apoptosis. Biochem Biophys Res Commun 2008; 374:175-80; PMID:18601905; DOI:10.1016/j.bbrc.2008.06.098.
26. Lee YI, Kang-Park S, Do SI, Lee YI. The hepatitis B virus-X protein activates a phosphatidylinositol- 3-kinase-dependent survival signaling cascade. J Biol Chem 2001; 276:16969-77; PMID:11278872; DOI:10.1074/jbc.M011263200.
27. Tannapfel A, Wasner M, Krause K, Geissler F, Katalinic A, Hauss J, et al. Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma. J Natl Cancer Inst 1999; 91:1154-8; PMID:10393724; DOI:10.1093/jnci/91.13.1154.
28. Zawacka-Pankau J, Kostecka A, Sznarkowska A, Hedstrom E, Kawiak A. p73 tumor suppressor protein: a close relative of p53 not only in structure but also in anti-cancer approach? Cell Cycle 2010; 9:720-8; PMID:20160513; DOI:10.4161/cc.9.4.10668.
29. Melino G, De Laurenzi V, Vousden KH. p73: Friend or foe in tumorigenesis. Nat Rev Cancer 2002; 2:605-15; PMID:12154353; DOI:10.1038/nrc861.
30. Buhlmann S, Putzer BM. DNp73 a matter of cancer: mechanisms and clinical implications. Biochim Biophys Acta 2008; 1785:207-16; PMID: 18302944.
31. Irwin M, Marin MC, Phillips AC, Seelan RS, Smith DI, Liu W, et al. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 2000; 407:645-8; PMID:11034215; DOI:10.1038/35036614.
32. Stiewe T, Putzer BM. Role of the p53-homologue p73 in E2F1-induced apoptosis. Nat Genet 2000; 26:464-9; PMID:11101847; DOI:10.1038/82617.
33. Nakagawa T, Takahashi M, Ozaki T, Watanabe K, Hayashi S, Hosoda M, et al. Negative autoregulation of p73 and p53 by DeltaNp73 in regulating differentiation and survival of human neuroblastoma cells. Cancer Lett 2003; 197:105-9; PMID:12880968; DOI:10.1016/S0304-3835(03)00090-9.
34. Grob TJ, Novak U, Maisse C, Barcaroli D, Luthi AU, Pirnia F, et al. Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ 2001; 8:1213-23; PMID:11753569; DOI:10.1038/sj.cdd.4400962.
35. Stiewe T, Theseling CC, Putzer BM. Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis. J Biol Chem 2002; 277:14177-85; PMID:11844800; DOI:10.1074/jbc.M200480200.
36. Slade N, Zaika AI, Erster S, Moll UM. DeltaNp73 stabilises TAp73 proteins but compromises their function due to inhibitory hetero-oligomer formation. Cell Death Differ 2004; 11:357-60; PMID:14685155; DOI:10.1038/sj.cdd.4401335.
37. Stiewe T, Stanelle J, Theseling CC, Pollmeier B, Beitzinger M, Putzer BM. Inactivation of retinoblastoma (RB) tumor suppressor by oncogenic isoforms of the p53 family member p73. J Biol Chem 2003; 278:14230-6; PMID:12584188; DOI:10.1074/jbc.M300357200.
38. Petrenko O, Zaika A, Moll UM. deltaNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo. Mol Cell Biol 2003; 23:5540-55; PMID:12897129; DOI:10.1128/MCB.23.16.5540-55.2003.
39. Stiewe T, Zimmermann S, Frilling A, Esche H, Putzer BM. Transactivation-deficient DeltaTA-p73 acts as an oncogene. Cancer Res 2002; 62:3598-602; PMID:12097259.
40. Emmrich S, Wang W, John K, Li W, Putzer BM. Antisense gapmers selectively suppress individual oncogenic p73 splice isoforms and inhibit tumor growth in vivo. Mol Cancer 2009; 8:61; PMID:19671150; DOI:10.1186/1476-4598-8-61.
41. Tomasini R, Tsuchihara K, Wilhelm M, Fujitani M, Rufini A, Cheung CC, et al. TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev 2008; 22:2677-91; PMID:18805989; DOI:10.1101/gad.1695308.
42. Wilhelm MT, Rufini A, Wetzel MK, Tsuchihara K, Inoue S, Tomasini R, et al. Isoform-specific p73 knockout mice reveal a novel role for delta Np73 in the DNA damage response pathway. Genes Dev 2010; 24:549-60; PMID:20194434; DOI:10.1101/gad.1873910.
43. Tannapfel A, John K, Mise N, Schmidt A, Buhlmann S, Ibrahim SM, et al. Autonomous growth and hepatocarcinogenesis in transgenic mice expressing the p53 family inhibitor DNp73. Carcinogenesis 2008; 29:211-8; PMID:17984115; DOI:10.1093/carcin/bgm236.
44. Müller M, Schilling T, Sayan AE, Kairat A, Lorenz K, Schulze-Bergkamen H, et al. TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. Cell Death Differ 2005; 12:1564-77; PMID:16195739; DOI:10.1038/sj.cdd.4401774.
45. Stiewe T, Tuve S, Peter M, Tannapfel A, Elmaagacli AH, Putzer BM. Quantitative TP73 transcript analysis in hepatocellular carcinomas. Clin Cancer Res 2004; 10:626-33; PMID:14760085; DOI:10.1158/1078-0432.CCR-0153-03.
46. Schuster A, Schilling T, De Laurenzi V, Koch AF, Seitz S, Staib F, et al. DeltaNp73beta is oncogenic in hepatocellular carcinoma by blocking apoptosis signaling via death receptors and mitochondria. Cell Cycle 2010; 9:2629-39; PMID:20581467; DOI:10.4161/cc.9.13.12110.
47. Liang SH, Clarke MF. Regulation of p53 localization. Eur J Biochem 2001; 268:2779-83; PMID:11358492; DOI:10.1046/j.1432-327.2001.02227.x.
48. Kekulé AS, Lauer U, Weiss L, Luber B, Hofschneider PH. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 1993; 361:742-5; PMID:8441471; DOI:10.1038/361742a0.
49. Luber B, Lauer U, Weiss L, Hohne M, Hofschneider PH, Kekule AS. The hepatitis B virus transactivator HBx causes elevation of diacylglycerol and activation of protein kinase C. Res Virol 1993; 144:311-21; PMID:8210715; DOI:10.1016/S0923-2516(06)80047-6.
50. Lucito R, Schneider RJ. Hepatitis B virus X protein activates transcription factor NFkappaB without a requirement for protein kinase C. J Virol 1992; 66:983-91; PMID:1309924
51. Murakami S, Cheong J, Ohno S, Matsushima K, Kaneko S. Transactivation of human hepatitis B virus X protein, HBx, operates through a mechanism distinct from protein kinase C and okadaic acid activation pathways. Virology 1994; 199:243-6; PMID:8116251; DOI:10.1006/viro.1994.1119.
52. Scotto C, Delphin C, Deloulme JC, Baudier J. Concerted regulation of wild-type p53 nuclear accumulation and activation by S100B and calcium-dependent protein kinase C. Mol Cell Biol 1999; 19:7168-80; PMID:10490652.
53. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 1998; 281:1674-7; PMID:9733514; DOI:10.1126/science.281.5383.1674.
54. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 1998; 281:1677-9; PMID:9733515; DOI:10.1126/science.281.5383.1677.
55. Appella E, Anderson CW. Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 2001; 268:2764-72; PMID:11358490; DOI:10.1046/j.1432-327.2001.02225.x.
56. Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, Cliby WA, Shieh SY, et al. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev 1999; 13:152-7; PMID:9925639; DOI:10.1101/gad.13.2.152.
57. Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003; 421:499-506; PMID:12556884; DOI:10.1038/nature01368.
58. Sung WK, Lu Y, Lee CW, Zhang D, Ronaghi M, Lee CG. Deregulated direct targets of the hepatitis B virus (HBV) protein, HBx, identified through chromatin immunoprecipitation and expression microarray profiling. J Biol Chem 2009; 284:21941-54; PMID:19439406; DOI:10.1074/jbc.M109.014563.
59. Ueda H, Ullrich SJ, Gangemi JD, Kappel CA, Ngo L, Feitelson MA, et al. Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet 1995; 9:41-7; PMID:7704023; DOI:10.1038/ng0195-41.
60. Coutandin D, Lohr F, Niesen FH, Ikeya T, Weber TA, Schafer B, et al. Conformational stability and activity of p73 require a second helix in the tetramerization domain. Cell Death Differ 2009; 16:1582-9; PMID:19763140; DOI:10.1038/cdd.2009.139.
61. Joerger AC, Rajagopalan S, Natan E, Veprintsev DB, Robinson CV, Fersht AR. Structural evolution of p53, p63 and p73: implication for heterotetramer formation. Proc Natl Acad Sci USA 2009; 106:17705-10; PMID:19815500; DOI:10.1073/pnas.0905867106.
62. Mihara M, Nimura Y, Ichimiya S, Sakiyama S, Kajikawa S, Adachi W, et al. Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma. Br J Cancer 1999; 79:164-7; PMID:10408709; DOI:10.1038/sj.bjc.6690027.
63. Sayan BS, Yang AL, Conforti F, Tucci P, Piro MC, Browne GJ, et al. Differential control of TAp73 and DeltaNp73 protein stability by the ring finger ubiquitin ligase PIR2. Proc Natl Acad Sci USA 2010; 107:12877-82; PMID:20615966; DOI:10.1073/pnas.0911828107.
64. Teodoro JG, Branton PE. Regulation of p53-dependent apoptosis, transcriptional repression, and cell transformation by phosphorylation of the 55-kilodalton E1B protein of human adenovirus type 5. J Virol 1997; 71:3620-7; PMID:9094635.
65. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature 1997; 390:350-1; PMID:9389474; DOI:10.1038/37022.
66. Buhlmann S, Racek T, Schwarz A, Schaefer S, Putzer BM. Molecular mechanism of p73-mediated regulation of hepatitis B virus core promoter/enhancer II: implications for hepatocarcinogenesis. J Mol Biol 2008; 378:20-30; PMID:18342333; DOI:10.1016/j.jmb.2008.02.021.
67. Racek T, Buhlmann S, Rust F, Knoll S, Alla V, Putzer BM. Transcriptional repression of the prosurvival endoplasmic reticulum chaperone GRP78/BIP by E2F1. J Biol Chem 2008; 283:34305-14; PMID:18840615; DOI:10.1074/jbc.M803925200.
68. Kairat A, Beerheide W, Zhou G, Tang ZY, Edler L, Schroder CH. Truncated hepatitis B virus RNA in human hepatocellular carcinoma: its representation in patients with advancing age. Intervirology 1999; 42:228-37; PMID:10567841; DOI:10.1159/000024982.
69. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296:550-3; PMID:11910072; DOI:10.1126/science.1068999.
70. D'Orazi G, Cecchinelli B, Bruno T, Manni I, Higashimoto Y, Saito S, et al. Homeodomaininteracting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat Cell Biol 2002; 4:11-9; PMID:11780126; DOI:10.1038/ncb714.
71. Strano S, Munarriz E, Rossi M, Castagnoli L, Shaul Y, Sacchi A, et al. Physical interaction with Yesassociated protein enhances p73 transcriptional activity. J Biol Chem 2001; 276:15164-73; PMID:11278685; DOI:10.1074/jbc. M010484200.